Citation: A. Bahr et al., POINT MUTATIONS CAUSING BLOOMS-SYNDROME ABOLISH ATPASE AND DNA HELICASE ACTIVITIES OF THE BLM PROTEIN, Oncogene, 17(20), 1998, pp. 2565-2571
Citation: Rv. Gopalkrishnan et al., THE P53 TUMOR-SUPPRESSOR INHIBITS TRANSCRIPTION OF THE TATA-LESS MOUSE DP1 PROMOTER, The Journal of biological chemistry, 273(18), 1998, pp. 10972-10978
Citation: P. Lutz et al., THE PRODUCT OF THE ADENOVIRUS INTERMEDIATE GENE-IX IS A TRANSCRIPTIONAL ACTIVATOR, Journal of virology, 71(7), 1997, pp. 5102-5109
Authors:
BOEUF H
HAUSS C
DEGRAEVE F
BARAN N
KEDINGER C
Citation: H. Boeuf et al., LEUKEMIA INHIBITORY FACTOR-DEPENDENT TRANSCRIPTIONAL ACTIVATION IN EMBRYONIC STEM-CELLS, The Journal of cell biology, 138(6), 1997, pp. 1207-1217
Authors:
ACKER J
DEGRAAFF M
CHEYNEL I
KHAZAK V
KEDINGER C
VIGNERON M
Citation: J. Acker et al., INTERACTIONS BETWEEN THE HUMAN RNA-POLYMERASE-II SUBUNITS, The Journal of biological chemistry, 272(27), 1997, pp. 16815-16821
Authors:
GOPALKRISHNAN RV
DOLLE P
MATTEI MG
LATHANGUE NB
KEDINGER C
Citation: Rv. Gopalkrishnan et al., GENOMIC STRUCTURE AND DEVELOPMENTAL EXPRESSION OF THE MOUSE-CELL CYCLE REGULATORY TRANSCRIPTION FACTOR DP1, Oncogene, 13(12), 1996, pp. 2671-2680
Authors:
NGUYEN VT
GIANNONI F
DUBOIS MF
SEO SJ
VIGNERON M
KEDINGER C
BENSAUDE O
Citation: Vt. Nguyen et al., IN-VIVO DEGRADATION OF RNA-POLYMERASE-II LARGEST SUBUNIT TRIGGERED BYALPHA-AMANITIN, Nucleic acids research, 24(15), 1996, pp. 2924-2929
Authors:
LUTZ P
PUVIONDUTILLEUL F
LUTZ Y
KEDINGER C
Citation: P. Lutz et al., NUCLEOPLASMIC AND NUCLEOLAR DISTRIBUTION OF THE ADENOVIRUS IVA2 GENE-PRODUCT, Journal of virology, 70(6), 1996, pp. 3449-3460
Citation: P. Lutz et C. Kedinger, PROPERTIES OF THE ADENOVIRUS IVA2 GENE-PRODUCT, AN EFFECTOR OF LATE-PHASE-DEPENDENT ACTIVATION OF THE MAJOR LATE PROMOTER, Journal of virology, 70(3), 1996, pp. 1396-1405
Citation: B. Chatton et al., EUKARYOTIC GST FUSION VECTOR FOR THE STUDY OF PROTEIN-PROTEIN ASSOCIATIONS IN-VIVO - APPLICATION TO INTERACTION OF ATFA WITH JUN AND FOS, BioTechniques, 18(1), 1995, pp. 142-145
Citation: Jl. Bocco et al., RB MAY ACT AS A TRANSCRIPTIONAL COACTIVATOR IN UNDIFFERENTIATED F9 CELLS (VOL 8, PG 2977, 1993), Oncogene, 9(3), 1994, pp. 999-999
Authors:
CHATTON B
BOCCO JL
GOETZ J
GAIRE M
LUTZ Y
KEDINGER C
Citation: B. Chatton et al., JUN AND FOS HETERODIMERIZE WITH ATFA, A MEMBER OF THE ATF CREB FAMILYAND MODULATE ITS TRANSCRIPTIONAL ACTIVITY/, Oncogene, 9(2), 1994, pp. 375-385
Authors:
KEDINGER C
BOCCO JL
CHATTON B
REIMUND B
GOETZ J
GOPALKRISHNAN R
Citation: C. Kedinger et al., THE ADENOVIRUS E2A PROMOTER AS A PROBE FOR THE STUDY OF F9 CELL-DIFFERENTIATION, Journal of cellular biochemistry, 1994, pp. 223-223
Citation: C. Tribouley et al., PRODUCT OF THE ADENOVIRUS INTERMEDIATE GENE IVA2 IS A TRANSCRIPTIONALACTIVATOR OF THE MAJOR LATE PROMOTER, Journal of virology, 68(7), 1994, pp. 4450-4457
Authors:
ACKER J
WINTZERITH M
VIGNERON M
KEDINGER C
Citation: J. Acker et al., STRUCTURE OF THE GENE ENCODING THE 14.5 KDA SUBUNIT OF HUMAN RNA POLYMERASE-II, Nucleic acids research, 21(23), 1993, pp. 5345-5350